biotech

US still offering the most biotech names

Seven experts give their opinions

Clean energy and biotech

'Cause for optimism'

Outlook is favourable

China is experiencing significant demographic shifts, and these are spurring its emergence as a new player in innovative health care, says AXA IM's Cinney Zhang.

Fuelled by innovation, the outlook for the biotech sector remains positive and should be viewed separately from the macro environment, says Peter Hughes.

Discipline, experience and caution required

Disproportionately smaller investment

Ageing population underpinning demand